Curis Lifesciences IPO Sees Exceptional Demand, Subscribed 74.39x on Day 3

Curis Lifesciences Limited's initial public offering (IPO) has demonstrated exceptional investor interest through its third day of subscription. The stock price band is set at ₹120-128 per share. The ₹27.52 crore IPO reached 74.39 times by 5:44:59 PM on day three. 

Curis Lifesciences IPO non-institutional investors segment leads with exceptional 115.46 times subscription. Qualified institutional buyers demonstrate exceptional participation at 96.17 times. Individual investors display exceptional interest at 44.28 times. Anchor investors show complete participation at 1.00 times. Market makers show complete participation at 1.00 times.

Curis Lifesciences IPO subscription reached exceptional 74.39 times on day three. It was led by Non-Institutional Investors (115.46x), Qualified Institutional Buyers Ex-Anchor (96.17x), and Individual Investors (44.28x). Total applications reached 21,473.

Invest in Indian Markets and Unlock Future Potential With 5paisa!

Open Account Now

Subscription Status of Curis Lifesciences IPO:

Here are the subscription details for Curis Lifesciences IPO as of Day 3 (November 11, 2025, 5:44:59 PM):

Key Highlights - Day 3:

• Overall subscription reached exceptional 74.39 times, showing extraordinary improvement from day two's 5.15 times
• Qualified institutional buyers (ex-anchor) showing exceptional performance at 96.17 times, building dramatically from day two's 8.34 times, indicating very strong institutional interest
• Individual investors displaying exceptional confidence at 44.28 times, building substantially from day two's 3.80 times, indicating robust retail demand for this SME IPO
• Total applications reached 21,473, showing exceptional investor participation for this SME IPO
• Cumulative bid amount reached ₹1,364.53 crores, significantly exceeding the net offer size of ₹26.14 crores (excluding anchor and market maker portions) by over 52 times
• Anchor investors fully subscribed their allocation of ₹7.80 crores on November 6, 2025

Curis Lifesciences IPO - Day 2 Subscription at 5.15 Times

Key Highlights - Day 2:

• Overall subscription reached strong 5.15 times, showing substantial improvement from day one's 3.07 times
• Qualified institutional buyers showing strong performance at 8.34 times, unchanged from day one's 8.34 times
• Non-institutional investors displaying strong confidence at 4.06 times, building substantially from day one's 1.19 times
• Individual investors showing strong performance at 3.80 times, building substantially from day one's 0.87 times

Curis Lifesciences IPO - Day 1 Subscription at 3.07 Times

Key Highlights - Day 1:

• Overall subscription reached moderate 1.07 times, showing positive initial investor interest
• Individual investors showing moderate performance at 1.92 times, indicating measured retail sentiment
• Non-institutional investors displaying weak confidence at 0.23 times, showing subdued HNI appetite

About Curis Lifesciences Limited

Incorporated in 2010, Curis Lifesciences Limited is a pharmaceutical company that specializes in developing, manufacturing, and distributing a diverse range of products. The company manufactures pharmaceutical products globally and domestically on a loan license or contract basis, as well as for its own brand marketing.